Title: Full Text of HB3129
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Full Text of HB3129 ILGA.GOV HB3129 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026HB3129 Introduced 2/18/2025, by Rep. William E Hauter SYNOPSIS AS INTRODUCED: 720 ILCS 570/208  from Ch. 56 1/2, par. 1208720 ILCS 642/Act rep.    Amends the Illinois Controlled Substances Act. Adds mitragynine and 7-hydroxymitragynine as Schedule III controlled substances. Repeals the Kratom Control Act.LRB104 08036 RLC 18082 b  A BILL FOR HB3129LRB104 08036 RLC 18082 b1    AN ACT concerning criminal law. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Illinois Controlled Substances Act is 5amended by changing Section 208 as follows: 6    (720 ILCS 570/208)  (from Ch. 56 1/2, par. 1208)7    Sec. 208. (a) The controlled substances listed in this 8Section are included in Schedule III.9    (b) Unless specifically excepted or unless listed in 10another schedule, any material, compound, mixture, or 11preparation which contains any quantity of the following 12substances having a stimulant effect on the central nervous 13system, including its salts, isomers (whether optical 14position, or geometric), and salts of such isomers whenever 15the existence of such salts, isomers, and salts of isomers is 16possible within the specific chemical designation;17        (1) Those compounds, mixtures, or preparations in 18    dosage unit form containing any stimulant substances 19    listed in Schedule II which compounds, mixtures, or 20    preparations were listed on August 25, 1971, as excepted 21    compounds under Title 21, Code of Federal Regulations, 22    Section 308.32, and any other drug of the quantitative 23    composition shown in that list for those drugs or which is   HB3129- 2 -LRB104 08036 RLC 18082 b1    the same except that it contains a lesser quantity of 2    controlled substances;3        (2) Benzphetamine;4        (3) Chlorphentermine;5        (4) Clortermine;6        (5) Phendimetrazine.7    (c) Unless specifically excepted or unless listed in 8another schedule, any material, compound, mixture, or 9preparation which contains any quantity of the following 10substances having a potential for misuse associated with a 11depressant effect on the central nervous system:12        (1) Any compound, mixture, or preparation containing 13    amobarbital, secobarbital, pentobarbital or any salt 14    thereof and one or more other active medicinal ingredients 15    which are not listed in any schedule;16        (2) Any suppository dosage form containing 17    amobarbital, secobarbital, pentobarbital or any salt of 18    any of these drugs and approved by the Federal Food and 19    Drug Administration for marketing only as a suppository;20        (3) Any substance which contains any quantity of a 21    derivative of barbituric acid, or any salt thereof:22        (3.1) Aprobarbital;23        (3.2) Butabarbital (secbutabarbital);24        (3.3) Butalbital;25        (3.4) Butobarbital (butethal); 26        (4) Chlorhexadol;  HB3129- 3 -LRB104 08036 RLC 18082 b1        (5) Methyprylon;2        (6) Sulfondiethylmethane;3        (7) Sulfonethylmethane;4        (8) Sulfonmethane;5        (9) Lysergic acid;6        (10) Lysergic acid amide;7        (10.1) Tiletamine or zolazepam or both, or any salt of 8    either of them.9    Some trade or other names for a tiletamine-zolazepam 10    combination product: Telazol. 11    Some trade or other names for Tiletamine: 12    2-(ethylamino)-2-(2-thienyl)-cyclohexanone. 13    Some trade or other names for zolazepam: 14    4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo- 15    [3,4-e], [1,4]-diazepin-7(1H)-one, and flupyrazapon.16        (11) Any material, compound, mixture or preparation 17    containing not more than 12.5 milligrams of pentazocine or 18    any of its salts, per 325 milligrams of aspirin;19        (12) Any material, compound, mixture or preparation 20    containing not more than 12.5 milligrams of pentazocine or 21    any of its salts, per 325 milligrams of acetaminophen;22        (13) Any material, compound, mixture or preparation 23    containing not more than 50 milligrams of pentazocine or 24    any of its salts plus naloxone HCl USP 0.5 milligrams, per 25    dosage unit;26        (14) Ketamine;  HB3129- 4 -LRB104 08036 RLC 18082 b1        (15) Thiopental. 2    (d) Nalorphine.3    (d.5) Buprenorphine. 4    (e) Unless specifically excepted or unless listed in 5another schedule, any material, compound, mixture, or 6preparation containing limited quantities of any of the 7following narcotic drugs, or their salts calculated as the 8free anhydrous base or alkaloid, as set forth below:9        (1) not more than 1.8 grams of codeine per 100 10    milliliters or not more than 90 milligrams per dosage 11    unit, with an equal or greater quantity of an isoquinoline 12    alkaloid of opium;13        (2) not more than 1.8 grams of codeine per 100 14    milliliters or not more than 90 milligrams per dosage 15    unit, with one or more active non-narcotic ingredients in 16    recognized therapeutic amounts;17        (3) (blank);18        (4) (blank);19        (5) not more than 1.8 grams of dihydrocodeine per 100 20    milliliters or not more than 90 milligrams per dosage 21    unit, with one or more active, non-narcotic ingredients in 22    recognized therapeutic amounts;23        (6) not more than 300 milligrams of ethylmorphine per 24    100 milliliters or not more than 15 milligrams per dosage 25    unit, with one or more active, non-narcotic ingredients in 26    recognized therapeutic amounts;  HB3129- 5 -LRB104 08036 RLC 18082 b1        (7) not more than 500 milligrams of opium per 100 2    milliliters or per 100 grams, or not more than 25 3    milligrams per dosage unit, with one or more active, 4    non-narcotic ingredients in recognized therapeutic 5    amounts;6        (8) not more than 50 milligrams of morphine per 100 7    milliliters or per 100 grams with one or more active, 8    non-narcotic ingredients in recognized therapeutic 9    amounts.10    (f) Anabolic steroids, except the following anabolic 11steroids that are exempt:12        (1) Androgyn L.A.;13        (2) Andro-Estro 90-4;14        (3) depANDROGYN;15        (4) DEPO-T.E.;16        (5) depTESTROGEN;17        (6) Duomone;18        (7) DURATESTRIN;19        (8) DUO-SPAN II;20        (9) Estratest;21        (10) Estratest H.S.;22        (11) PAN ESTRA TEST;23        (12) Premarin with Methyltestosterone;24        (13) TEST-ESTRO Cypionates;25        (14) Testosterone Cyp 50 Estradiol Cyp 2;26        (15) Testosterone Cypionate-Estradiol Cypionate   HB3129- 6 -LRB104 08036 RLC 18082 b1    injection; and2        (16) Testosterone Enanthate-Estradiol Valerate 3    injection.4    (g) Hallucinogenic substances.5        (1) Dronabinol (synthetic) in sesame oil and 6    encapsulated in a soft gelatin capsule in a U.S. Food and 7    Drug Administration approved product. Some other names for 8    dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro- 9    6,6,9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1-ol) or 10    (-)-delta-9-(trans)-tetrahydrocannabinol.11        (2) (Reserved).12    (h) The Department may except by rule any compound, 13mixture, or preparation containing any stimulant or depressant 14substance listed in subsection (b) from the application of all 15or any part of this Act if the compound, mixture, or 16preparation contains one or more active medicinal ingredients 17not having a stimulant or depressant effect on the central 18nervous system, and if the admixtures are included therein in 19combinations, quantity, proportion, or concentration that 20vitiate the potential for misuse of the substances which have 21a stimulant or depressant effect on the central nervous 22system.23    (i) Mitragynine.24    (j) 7-hydroxymitragynine. 25(Source: P.A. 103-881, eff. 1-1-25.)   HB3129- 7 -LRB104 08036 RLC 18082 b1    (720 ILCS 642/Act rep.)2    Section 10. The Kratom Control Act is repealed.


================================================================================

Raw Text:
Full Text of HB3129 ILGA.GOV HB3129 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026HB3129 Introduced 2/18/2025, by Rep. William E Hauter SYNOPSIS AS INTRODUCED: 720 ILCS 570/208  from Ch. 56 1/2, par. 1208720 ILCS 642/Act rep.    Amends the Illinois Controlled Substances Act. Adds mitragynine and 7-hydroxymitragynine as Schedule III controlled substances. Repeals the Kratom Control Act.LRB104 08036 RLC 18082 b  A BILL FOR HB3129LRB104 08036 RLC 18082 b1    AN ACT concerning criminal law. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Illinois Controlled Substances Act is 5amended by changing Section 208 as follows: 6    (720 ILCS 570/208)  (from Ch. 56 1/2, par. 1208)7    Sec. 208. (a) The controlled substances listed in this 8Section are included in Schedule III.9    (b) Unless specifically excepted or unless listed in 10another schedule, any material, compound, mixture, or 11preparation which contains any quantity of the following 12substances having a stimulant effect on the central nervous 13system, including its salts, isomers (whether optical 14position, or geometric), and salts of such isomers whenever 15the existence of such salts, isomers, and salts of isomers is 16possible within the specific chemical designation;17        (1) Those compounds, mixtures, or preparations in 18    dosage unit form containing any stimulant substances 19    listed in Schedule II which compounds, mixtures, or 20    preparations were listed on August 25, 1971, as excepted 21    compounds under Title 21, Code of Federal Regulations, 22    Section 308.32, and any other drug of the quantitative 23    composition shown in that list for those drugs or which is   HB3129- 2 -LRB104 08036 RLC 18082 b1    the same except that it contains a lesser quantity of 2    controlled substances;3        (2) Benzphetamine;4        (3) Chlorphentermine;5        (4) Clortermine;6        (5) Phendimetrazine.7    (c) Unless specifically excepted or unless listed in 8another schedule, any material, compound, mixture, or 9preparation which contains any quantity of the following 10substances having a potential for misuse associated with a 11depressant effect on the central nervous system:12        (1) Any compound, mixture, or preparation containing 13    amobarbital, secobarbital, pentobarbital or any salt 14    thereof and one or more other active medicinal ingredients 15    which are not listed in any schedule;16        (2) Any suppository dosage form containing 17    amobarbital, secobarbital, pentobarbital or any salt of 18    any of these drugs and approved by the Federal Food and 19    Drug Administration for marketing only as a suppository;20        (3) Any substance which contains any quantity of a 21    derivative of barbituric acid, or any salt thereof:22        (3.1) Aprobarbital;23        (3.2) Butabarbital (secbutabarbital);24        (3.3) Butalbital;25        (3.4) Butobarbital (butethal); 26        (4) Chlorhexadol;  HB3129- 3 -LRB104 08036 RLC 18082 b1        (5) Methyprylon;2        (6) Sulfondiethylmethane;3        (7) Sulfonethylmethane;4        (8) Sulfonmethane;5        (9) Lysergic acid;6        (10) Lysergic acid amide;7        (10.1) Tiletamine or zolazepam or both, or any salt of 8    either of them.9    Some trade or other names for a tiletamine-zolazepam 10    combination product: Telazol. 11    Some trade or other names for Tiletamine: 12    2-(ethylamino)-2-(2-thienyl)-cyclohexanone. 13    Some trade or other names for zolazepam: 14    4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo- 15    [3,4-e], [1,4]-diazepin-7(1H)-one, and flupyrazapon.16        (11) Any material, compound, mixture or preparation 17    containing not more than 12.5 milligrams of pentazocine or 18    any of its salts, per 325 milligrams of aspirin;19        (12) Any material, compound, mixture or preparation 20    containing not more than 12.5 milligrams of pentazocine or 21    any of its salts, per 325 milligrams of acetaminophen;22        (13) Any material, compound, mixture or preparation 23    containing not more than 50 milligrams of pentazocine or 24    any of its salts plus naloxone HCl USP 0.5 milligrams, per 25    dosage unit;26        (14) Ketamine;  HB3129- 4 -LRB104 08036 RLC 18082 b1        (15) Thiopental. 2    (d) Nalorphine.3    (d.5) Buprenorphine. 4    (e) Unless specifically excepted or unless listed in 5another schedule, any material, compound, mixture, or 6preparation containing limited quantities of any of the 7following narcotic drugs, or their salts calculated as the 8free anhydrous base or alkaloid, as set forth below:9        (1) not more than 1.8 grams of codeine per 100 10    milliliters or not more than 90 milligrams per dosage 11    unit, with an equal or greater quantity of an isoquinoline 12    alkaloid of opium;13        (2) not more than 1.8 grams of codeine per 100 14    milliliters or not more than 90 milligrams per dosage 15    unit, with one or more active non-narcotic ingredients in 16    recognized therapeutic amounts;17        (3) (blank);18        (4) (blank);19        (5) not more than 1.8 grams of dihydrocodeine per 100 20    milliliters or not more than 90 milligrams per dosage 21    unit, with one or more active, non-narcotic ingredients in 22    recognized therapeutic amounts;23        (6) not more than 300 milligrams of ethylmorphine per 24    100 milliliters or not more than 15 milligrams per dosage 25    unit, with one or more active, non-narcotic ingredients in 26    recognized therapeutic amounts;  HB3129- 5 -LRB104 08036 RLC 18082 b1        (7) not more than 500 milligrams of opium per 100 2    milliliters or per 100 grams, or not more than 25 3    milligrams per dosage unit, with one or more active, 4    non-narcotic ingredients in recognized therapeutic 5    amounts;6        (8) not more than 50 milligrams of morphine per 100 7    milliliters or per 100 grams with one or more active, 8    non-narcotic ingredients in recognized therapeutic 9    amounts.10    (f) Anabolic steroids, except the following anabolic 11steroids that are exempt:12        (1) Androgyn L.A.;13        (2) Andro-Estro 90-4;14        (3) depANDROGYN;15        (4) DEPO-T.E.;16        (5) depTESTROGEN;17        (6) Duomone;18        (7) DURATESTRIN;19        (8) DUO-SPAN II;20        (9) Estratest;21        (10) Estratest H.S.;22        (11) PAN ESTRA TEST;23        (12) Premarin with Methyltestosterone;24        (13) TEST-ESTRO Cypionates;25        (14) Testosterone Cyp 50 Estradiol Cyp 2;26        (15) Testosterone Cypionate-Estradiol Cypionate   HB3129- 6 -LRB104 08036 RLC 18082 b1    injection; and2        (16) Testosterone Enanthate-Estradiol Valerate 3    injection.4    (g) Hallucinogenic substances.5        (1) Dronabinol (synthetic) in sesame oil and 6    encapsulated in a soft gelatin capsule in a U.S. Food and 7    Drug Administration approved product. Some other names for 8    dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro- 9    6,6,9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1-ol) or 10    (-)-delta-9-(trans)-tetrahydrocannabinol.11        (2) (Reserved).12    (h) The Department may except by rule any compound, 13mixture, or preparation containing any stimulant or depressant 14substance listed in subsection (b) from the application of all 15or any part of this Act if the compound, mixture, or 16preparation contains one or more active medicinal ingredients 17not having a stimulant or depressant effect on the central 18nervous system, and if the admixtures are included therein in 19combinations, quantity, proportion, or concentration that 20vitiate the potential for misuse of the substances which have 21a stimulant or depressant effect on the central nervous 22system.23    (i) Mitragynine.24    (j) 7-hydroxymitragynine. 25(Source: P.A. 103-881, eff. 1-1-25.)   HB3129- 7 -LRB104 08036 RLC 18082 b1    (720 ILCS 642/Act rep.)2    Section 10. The Kratom Control Act is repealed.